N-[3-(3-cyclohexylhexahydropyridin-1-yl)phenyl]-4-hydroxy-3-methoxybenzenethanamide | 478401-24-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: N-[3-(3-cyclohexylhexahydropyridin-1-yl)phenyl]-4-hydroxy-3-methoxybenzenethanamide
• 英文别名: N-[3-(3-cyclohexylpiperidin-1-yl)phenyl]-4-hydroxy-3-methoxybenzenethanamide；N-[3-(3-cyclohexylpiperidin-1-yl)phenyl]-4-hydroxy-3-methoxyphenylacetamide；N-[3-(3-cyclohexylpiperidin-1-yl)phenyl]-2-(4-hydroxy-3-methoxyphenyl)acetamide
• CAS: 478401-24-0
• 化学式: C₂₆H₃₄N₂O₃
• 分子量: 422.568
• InChiKey: HGIDLVJHPAHTTP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.9
• 重原子数：
  31
• 可旋转键数：
  6
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  61.8
• 氢给体数：
  2
• 氢受体数：
  4

文献信息

• N-arylphenylacetamide derivatives and medicinal compositions containing the same
  申请人：——

  公开号：US20040248983A1

  公开（公告）日：2004-12-09

  N-Arylphenylacetamide derivatives represented by the following formula [I]: 1 (wherein R 1 is C 1-6 alkoxy, etc.; R 2 is hydrogen, —(CH 2 ) m —N(R 6 )(R 7 ) (m is an integer of from 1 to 4; R 6 is hydrogen, C 1-4 alkyl, etc., R 7 is hydrogen, etc.), etc.; R 3 is hydrogen, halogen, etc.; R 4 is C 6-10 alkyl, —Y—R 8 (Y is a single bond, C 1-6 alkylene, C 2-6 alkenylene, C 2-6 alkynylene, etc., R 8 is aryl, C 3-8 cycloalkyl, C 6-15 polycycloalkyl, etc.), etc.; R 5 is hydrogen, etc.; and X 1 is hydrogen), or pharmaceutically acceptable salts thereof or hydrates or solvates of the same, and a pharmaceutical composition containing the same. These compounds are useful as preventives and/or remedies giving no pain at the early stage of administration, which are efficacious in oral administration and have potent analgesic and antiinflammatory effects.

  下列式子所代表的N-Arylphenylacetamide衍生物[I]：1（其中R1是C1-6烷氧基等；R2是氢，-(CH2)m-N(R6)(R7)（m是从1到4的整数；R6是氢，C1-4烷基等，R7是氢等）等；R3是氢，卤素等；R4是C6-10烷基，-Y-R8（Y是单键，C1-6烷基，C2-6烯基，C2-6炔基等，R8是芳基，C3-8环烷基，C6-15多环烷基等）等；R5是氢等；X1是氢），或其药学上可接受的盐或其水合物或溶剂合物，以及含有它们的药物组成物。这些化合物在口服时具有强效的镇痛和抗炎作用，可用作早期给药时无痛的预防和/或治疗。
• N-ARYLPHENYLACETAMIDE DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME
  申请人：Dainippon Pharmaceutical Co., Ltd.

  公开号：EP1403235A1

  公开（公告）日：2004-03-31

  N-Arylphenylacetamide derivatives represented by the following formula [I]: (wherein R1 is C1-6 alkoxy, etc.; R2 is hydrogen, -(CH2)m-N(R6)(R7) (m is an integer of from 1 to 4; R6 is hydrogen, C1-4 alkyl, etc., R7 is hydrogen, etc.), etc.; R3 is hydrogen, halogen, etc.; R4 is C6-10 alkyl, -Y-R8 (Y is a single bond, C1-6 alkylene, C2-6 alkenylene, C2-6 alkynylene, etc., R8 is aryl, C3-8 cycloalkyl, C6-15 polycycloalkyl, etc.), etc.; R5 is hydrogen, etc.; and X1 is hydrogen), or pharmaceutically acceptable salts thereof or hydrates or solvates of the same, and a pharmaceutical composition containing the same. These compounds are useful as preventives and/or remedies giving no pain at the early stage of administration, which are efficacious in oral administration and have potent analgesic and antiinflammatory effects.

  下式[I]代表的 N-芳基苯乙酰胺衍生物： (其中 R1 是 C1-6 烷氧基等；R2 是氢、-(CH2)m-N(R6)(R7)（m 是 1 至 4 的整数；R6 是氢、C1-4 烷基等，R7 是氢等）等；R3 是氢、卤素等；R4 是 C6-10 烷基、-Y-R8（Y 是单键、C1-6 烯基、C2-6 烯基、C2-6 烯炔基等、R8为芳基、C3-8环烷基、C6-15多环烷基等）等；R5为氢等；X1为氢），或其药学上可接受的盐或其水合物或溶液，以及含有这些化合物的药物组合物。这些化合物可作为预防药物和/或治疗药物，用药初期无疼痛感，口服有效，并具有强效镇痛和抗炎作用。
• US7084176B2
  申请人：——

  公开号：US7084176B2

  公开（公告）日：2006-08-01